Structure

InChI Key QZZUEBNBZAPZLX-QFIPXVFZSA-N
Smile CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2
InChI
InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H28N2O3
Molecular Weight 392.5
AlogP 3.15
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 6.0
Polar Surface Area 85.35
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 29.0

Pharmacology

Primary Target
β2-adrenoceptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pulmonary Disease, Chronic Obstructive 3 D029424 ClinicalTrials
Heart Failure 3 D006333 ClinicalTrials
Asthma 3 D001249 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 312753-06-3
ChEBI 68575
ChEMBL CHEMBL1095777
DrugBank DB05039
DrugCentral 4183
EPA CompTox DTXSID90185198
FDA SRS 8OR09251MQ
Human Metabolome Database HMDB0015608
Guide to Pharmacology 7455
PharmGKB PA165958348
PubChem 6918554
SureChEMBL SCHEMBL48098
ZINC ZINC000035801098